Henrik Kristian Moltke
Director/Board Member presso INITIATOR PHARMA A/S
Provenienza dei contatti di primo grado di Henrik Kristian Moltke
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 10 | |
10
| Public Company | Biotechnology | 10 |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.
10
| Private Company | Pharmaceuticals: Major | 10 |
StemCare A/S
 StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark.
6
| Subsidiary | Biotechnology | 6 |
| Public Company | Pharmaceuticals: Major | 3 | |
Hartmanns A/S
 Hartmanns A/S Personnel ServicesCommercial Services Hartmanns A/S produces molded fiber packaging. The company is headquartered in Ballerup, Denmark.
1
| Subsidiary | Personnel Services | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Henrik Kristian Moltke tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| EUROCINE VACCINES AB | Pharmaceuticals: Major | Director/Board Member | |
| ABLIVA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ACTIVE BIOTECH AB | Biotechnology | Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
Danmarks Eksport- og Investeringsfond
 Danmarks Eksport- og Investeringsfond Investment ManagersFinance Danmarks Eksport- og Investeringsfond (EIFO) is a venture capital subsidiary of Government of Denmark and founded in 1992. The firm is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Director/Board Member | |
SBL Vaccin AB
 SBL Vaccin AB Pharmaceuticals: MajorHealth Technology SBL Vaccin AB manufactures and distributes vaccines. Its products are used for the treatment of polio, diarrhoea, and cholera diseases. The company distributes products to the healthcare centers, hospitals, schools, and industrial healthcare units. SBL Vaccin was founded in 1957 and is located in Solna, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Philadelphia University | College/University | Graduate Degree | |
| INSEAD | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
| Copenhagen Business School | College/University | Masters Business Admin Masters Business Admin Graduate Degree Undergraduate Degree | |
| University of Aarhus | College/University | Director/Board Member Doctorate Degree Corporate Officer/Principal Graduate Degree | |
Accuro Immunology AB
 Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Lund | College/University | Doctorate Degree Graduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| Scandinavian International Management Institute | College/University | Masters Business Admin Masters Business Admin | |
| FORWARD PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Biotechnology | Chairman Chief Executive Officer Chief Executive Officer | |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Chairman Chief Executive Officer | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Chief Executive Officer Corporate Officer/Principal | |
Caerus Consulting AS
 Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
Contera Pharma ApS
 Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Director/Board Member Chief Operating Officer | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
Conrig Pharma ApS
 Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Conrig Pharma ApS provides drug for oral treatment of atopical disease. Its new drug (CRG-010) is use for topical treatment of itch/pruritus associated with atopical dermatitis. The company was founded by John Bondo Hansen and Mikael Sondergaard Thomsen on December 20, 2010 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Founder Director/Board Member | |
| PEPTONIC MEDICAL AB | Pharmaceuticals: Major | Director/Board Member | |
Allarity Therapeutics Europe ApS
 Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member Corporate Officer/Principal | |
| Analgesia Partnership | Corporate Officer/Principal | ||
CellProtect Nordic Pharmaceuticals AB
 CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Part of XNK Therapeutics AB, CellProtect Nordic Pharmaceuticals AB is a clinical-stage biotechnology company based in Huddinge, SE. CellProtect Nordic Pharmaceuticals is one of the pioneering companies in the field of cell therapy, developing unique and individualized natural killer (NK) cell-based cancer therapies. The Swedish company has built a tailor-made GMP clean room facility for manufacturing clinical products and is currently evaluating its lead product, evencaleucel, in a randomized, controlled, phase II study for the treatment of multiple myeloma. The private company was founded in 2012 and the CEO is Johan Liwing. | Pharmaceuticals: Major | Director/Board Member | |
Disruptive Materials AB
 Disruptive Materials AB Chemicals: Major DiversifiedProcess Industries Disruptive Materials AB manufactures mesoporous magnesium carbonate. It focuses on commercializing the material Upsalite that can be used in applications such as desiccant for humidity control, pharmaceutics, adsorbent for waste handling, thermal and acoustic insulation, cosmetics, adsorbent in ink jet paper,and bio material applications. The company was founded by Johan A. V. Gómez de la Torre, Maria Strømme, Lars-Erik Mattias Karls, and Sara Kristina Frykstrand Ångström in December 2011 and is headquartered in Uppsala, Sweden. | Chemicals: Major Diversified | Director/Board Member | |
| COMBIGENE AB | Pharmaceuticals: Major | Chairman | |
| ALLARITY THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Director of Finance/CFO | |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
STipe Therapeutics ApS
 STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Combigene Uk Ltd. | Chairman | ||
Combigene Personal AB
 Combigene Personal AB Investment Banks/BrokersFinance Combigene Personal AB provides securities services. The private company is based in Hassleholm, Sweden. | Investment Banks/Brokers | Chairman | |
| ALZINOVA AB | Pharmaceuticals: Major | Director/Board Member | |
Panion Animal Health AB
 Panion Animal Health AB Agricultural Commodities/MillingProcess Industries Panion Animal Health AB engages in the development and commercialization of gene-therapeutic treatment of epileptic-type disorders in dogs and other animals. It specializes in combining modern neuroscience with recent advances in gene delivery. The company was founded in July 2015 and is headquartered in Hassleholm, Sweden. | Agricultural Commodities/Milling | Chairman | |
Cline Scientific AB
 Cline Scientific AB BiotechnologyHealth Technology Cline Scientific AB engages in the development and marketing of biomedical products for stem cell and cancer research. It offers nano gradient surfaces, nano surfaces, gold nanoparticles, and silver nanoparticles. The company was founded by Niklas Holmquist, Jenny Lindström, and Anders Patrik Sundh on September 26, 2011 and is headquartered in Gothenburg, Sweden. | Biotechnology | Director/Board Member | |
| Ankor Consultants Ltd. | Chief Executive Officer |
Statistiche
Distribuzione geografica
| Svezia | 23 |
| Danimarca | 15 |
| Stati Uniti | 6 |
| Francia | 3 |
| Norvegia | 3 |
Settori
| Health Technology | 28 |
| Consumer Services | 10 |
| Finance | 4 |
| Distribution Services | 3 |
| Commercial Services | 3 |
Posizioni
| Director/Board Member | 225 |
| Corporate Officer/Principal | 73 |
| Chairman | 58 |
| Independent Dir/Board Member | 47 |
| Chief Executive Officer | 45 |
Contatti più connessi
- Borsa valori
- Insiders
- Henrik Kristian Moltke
- Connessioni Società
